Clinical Trials Directory

Trials / Unknown

UnknownNCT04090671

Evaluation of the Multidimensional Dyspnea Profile (MDP)

Das Multidimensionale Dyspnoe Profil (MDP) Bei COPD, Herzinsuffizienz Und Schlafapnoe

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Institut für Pneumologie Hagen Ambrock eV · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aim of this multicenter prospective cohort study is the evaluation of the multidimensional qualities of dyspnea in a number of diseases using the Multidimensional Dyspnea Profile (Banzett et al, ERJ 2015).

Detailed description

The study sites will examine patients with COPD (Chronic obstructive pulmonary disease) in state of acute exacerbation and in stable state, patients with congestive heart failure (CHF) in state of acute decompensated cardiac insufficiency, and patients newly diagnosed with obstructive sleep apnea (OSA) as a control group. In the acute setting of COPD and CHF, the questionnaire will be given at the day of hospital admission and at the day of discharge. The patients will additionally fill the Severe Respiratory Insufficiency (SRI) Questionnaire (in COPD) or the Physical Activity Questionnaire 50+ (in CHF). In stable state of COPD, the questionnaires will be given once during a routine control visit at the hospital or the medical practice. In OSA, the questionnaire will be given once during the first visit in the sleep laboratory.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMultidimensional Dyspnea ProfileThe Multidimensional Dyspnea Profile measures the intensity of dyspneic breathing discomforts. It tests five sensory qualities that describe the patient's dyspnea in its respective intensity. Additionally it includes five potential reactions. The MDP is designed to refer to a specific event of time.

Timeline

Start date
2018-12-19
Primary completion
2023-12-01
Completion
2024-01-01
First posted
2019-09-16
Last updated
2023-07-14

Locations

4 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT04090671. Inclusion in this directory is not an endorsement.